Eton Pharmaceuticals, Inc. (ETON)

SEC filing

Eton Pharmaceuticals, Inc.

ETON · CIK 1710340

4 · Oct 6, 2026 · Chief Business Officer Krempa David sold 4,166 shares at $55.07/share ($229.4K); exercised options for 21.04K shares

Chief Business Officer Krempa David sold 4,166 shares at $55.07/share ($229.4K); exercised options for 21.04K shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).